Email Alerts
Tonix Pharmaceuticals trades on the OTCQB under the symbol TNXP
TONIX Pharmaceuticals
Home
Company Info
Overview
Management Team
Board of Directors
Scientific Advisory Board
Products
TNX-102 SL for Fibromyalgia
TNX-102 SL for PTSD
Therapeutics Areas
Overview
Fibromyalgia Syndrome
Post-traumatic Stress Disorder
Media Center
Press Releases
TONIX In The News
Presentations
Investor Relations
Overview
News / Events
Press Releases
TONIX In The News
IR Events
Presentations
Letters To Shareholders
Email Alerts
Company Information
Profile
Management Team
Contacts
FAQ
Financial Information
Financials
Conference Calls
Stock Information
Quote
Charts
Historical Quotes
SEC Filings
All SEC Filings
Section 16
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Contact Us
Press Releases
Media Center
Press Releases
TONIX In The News
Presentations
Home
Media Center
Press Releases
Tonix Pharmaceuticals Announces Reverse Split of Common Stock
May 1 2013, 9:05 AM EDT
Tonix Pharmaceuticals to Hold Annual Shareholders' Meeting on April 19, 2013
Apr 11 2013, 8:05 AM EDT
TONIX Completes Pre-Phase 3 Meeting With U.S. Food and Drug Administration for TNX-102 SL in Fibromyalgia
Mar 11 2013, 7:56 AM EDT
Tonix Pharmaceuticals to Present at the SeeThruEquity MicroCap Investor Forum on March 12
Mar 8 2013, 7:55 AM EST
Tonix Pharmaceuticals to Present at Upcoming Conferences
Feb 5 2013, 8:00 AM EST
Tonix Pharmaceuticals Completes $1 Million Financing With Technology Partners
Dec 27 2012, 8:00 AM EST
Tonix Pharmaceuticals Completes Private Placement
Dec 5 2012, 8:36 AM EST
Tonix Pharmaceuticals to Present at Fifth Annual LD Micro Conference
Dec 5 2012, 8:33 AM EST
Tonix Pharmaceuticals Completes Convertible Note Offering
Nov 14 2012, 4:15 PM EST
Tonix Pharmaceuticals Presents Research Findings at the 2012 American College of Rheumatology Annual Scientific Meeting
Nov 13 2012, 8:00 AM EST